DOLPAMINE AND COVID

here is the latest research findings

  • Brain Changes: Long COVID patients show 16–20% lower VMAT2 levels in the striatum, affecting motivation, memory, and movement.
  • Symptom Link: Reduced dopamine markers correlate with apathy, slowed movement, and memory issues, providing the first biological marker for long COVID.
  • Potential Treatments: Researchers are planning clinical trials using dopamine-related medications, aiming to restore nerve terminal function and alleviate symptoms.

Leave a comment